Imprimir

Point-Counterpoint: Piperacillin-Tazobactam Should Be Used To Treat Infections with Extended-Spectrum-Beta-Lactamase-Positive Organisms
Referencia:

J Clin Microbiol. 2018 Feb 22; 56(3):e01917-17. doi: 10.1128/JCM.01917-17. Print 2018 Mar. PMID: 29237787. PMCID: PMC5824049
Autores:

Schuetz AN; Reyes S; Tamma PD
Año: 2018
Enfoque: Resistencia Bacteriana
Descarga: https://www.ncbi.nlm.nih.gov/pubmed/29237787

[ Retroceder ]

 

 

 

Volver